Epidarex Capital Overview
Epidarex Capital is a transatlantic venture capital firm that invests in early-stage, high-growth life science companies in under-ventured markets in the United States and United Kingdom. The firm partners with entrepreneurs and leading research institutions to transform world-class science into innovative products addressing major unmet needs in the global healthcare market.
Is Epidarex Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Epidarex Capital, along with a list of other relevant VCs, is available on Hopohopo.io.
Epidarex Capital
Investment focus
Invest in
- Western Europe 1 / 14
- North America 1 / 5
Product type
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- Digital & Consumer health
- MedTech & Devices
- PharmaTech
Investment role
Lead and follow
Stages
Seed, Series A
First ticket size
£2,000,000 - £5,000,000
How to approach funds like Epidarex Capital
When approaching Epidarex Capital, founders should highlight the scientific rigor and commercial potential of their innovation, especially if it leverages unique research or IP from leading institutions. Demonstrate a clear path from lab to market, with a focus on addressing significant healthcare challenges. Emphasize your team's domain expertise and ability to execute in complex, regulated environments, as Epidarex values founders who can bridge the gap between breakthrough science and scalable business.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
